Hypertension, left ventricular hypertrophy and chronic kidney disease (Q37813472)

23 August 2017

1 reference

title

Hypertension, left ventricular hypertrophy and chronic kidney disease (English)

1 reference

left ventricular hypertrophy

23 August 2017

arterial hypertension

0 references

1 reference

3

0 references

author name string

Stefano Taddei

1

1 reference

23 August 2017

Renato Nami

2

1 reference

23 August 2017

Ilaria Quatrini

4

1 reference

23 August 2017

Ranuccio Nuti

5

1 reference

23 August 2017

1 November 2011

1 reference

23 August 2017

Heart Failure Reviews

1 reference

23 August 2017

16

1 reference

23 August 2017

615-620

1 reference

23 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-010-9197-z

23 August 2017

0 references

cites work

Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Importance of blood pressure control in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Hypertension in renal parenchymal disease: why is it so resistant to treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Sympathetic overactivity in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

The endothelin system and its antagonism in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Arterial stiffness and function in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Arterial calcification and pathology in uremic patients undergoing dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Arterial elastance and wave reflection augmentation of systolic blood pressure: deleterious effects and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Cardiovascular disease in chronic renal failure: pathophysiologic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Signaling pathways for cardiac hypertrophy and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Deleterious effect of altered myocardial fatty acid metabolism in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Left ventricular alterations and end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Pathophysiology of anaemia: focus on the heart and blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Anemia in chronic kidney disease and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

21 January 2018

12 December 2020

Canadian Randomized Trial of Hemoglobin Maintenance to Prevent or Delay Left Ventricular Mass Growth in Patients With CKD

1 reference

https://api.crossref.org/works/10.1007%2FS10741-010-9197-Z

Global burden of hypertension: analysis of worldwide data

21 January 2018

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy

1 reference

12 December 2020

Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications

1 reference

12 December 2020

Blood pressure and end-stage renal disease in men

1 reference

12 December 2020

[Left ventricular hypertrophy in chronic kidney disease]

1 reference

12 December 2020

Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency

1 reference

12 December 2020

Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes

1 reference

12 December 2020

Association of calcitriol and blood pressure in normotensive men

1 reference

12 December 2020

Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study

1 reference

12 December 2020

Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism

1 reference

12 December 2020

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

1 reference

12 December 2020

Left ventricular hypertrophy in the renal patient

1 reference

12 December 2020

Arterial stiffening and vascular calcifications in end-stage renal disease

1 reference

12 December 2020

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association

1 reference

12 December 2020

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors

1 reference

12 December 2020

United States Renal Data System 2008 Annual Data Report

1 reference

12 December 2020

The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented

1 reference

12 December 2020

10.1007/S10741-010-9197-Z

Identifiers

DOI

1 reference

23 August 2017

1 reference